Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

DuPont Merck evaluates new candidate cognition enhancer

Dec. 13, 1996

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

Dec. 13, 1996

Japanese academic researchers isolate new quassinoid compound

Dec. 10, 1996

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

New anxiolytic under development at Parke-Davis

Dec. 2, 1996

Antiepileptic agent reported by Parke-Davis

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...